Home » Psychology news » Diabetes drug shows promise for safely treating, detecting Alzheimer’s disease
Diabetes drug shows promise for safely treating, detecting Alzheimer’s disease
March 8, 2017 by NewsBot
Treatment with the diabetes drug amylin (or pramlintide) safely improves learning and memory function in Alzheimer's disease (AD) patients and reduces the AD pathology in their brains. The findings also may lead to the development of a blood test for AD.
